Breast shields better at reducing dose than posteriorly centered partial CT, study finds

The use of breast shields is the technique of choice to protect the breasts of women from radiation exposure while undergoing chest CT examinations, according to a new study.

The use of CT has grown exponentially which brings into question the level of radiation exposure to patients. Recently the International Commission of Radiation Protection (ICRP) increased the tissue weighting factor for the breast from 0.05 to 0.1 noting that is even more sensitive to than previously thought, said Rafel Tappouni, MD, the lead author of the study. To put the risk into perspective, the delivery of 1 rad to a 35 old woman is estimated to increase her lifetime risk of by 13.6%; each CT exam delivers at least twice that amount, he said.
.

Dr. Tappouni and his colleagues at Penn State Hershey Medical Center in Hershey, PA measured the to the front and back of a breast phantom (a object that mimics the size of the breast area of a person) using a breast shield and using a new technique called posteriorly-centered partial CT. In posteriorly centered partial CT, the turns on and off as it scans the patient. "We found that posteriorly centered partial CT does decrease skin entrance radiation dose to the breast by 16%, but increases overall radiation dose to the chest by 8%," said Dr. Tappouni. "The bismuth breast shields, on the other hand, reduced skin entrance dose to the breast by 38% without an increase in overall radiation dose," he said.

Dr. Tappouni noted that they now use breast shields at his facility for all female patients up to age 90 who undergo chest CT examinations.

More information: The study is being presented during the American Roentgen Ray Society Annual Meeting on May 4 in Chicago.

Provided by American Roentgen Ray Society

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Physicians target the genes of lung, colon cancers

3 hours ago

(Medical Xpress)—University of Florida physicians and researchers are collaborating to map the genes of different types of cancer, and then deliver medication to attack cancer at its source.

DNA alternative to Pap smear sparks medical debate (Update)

21 hours ago

A high-tech screening tool for cervical cancer is facing pushback from more than a dozen American patient groups, who warn that the genetic test could displace a simpler, cheaper and more established mainstay of women's health: ...

User comments